Phytoestrogens Induce Apoptosis via Extrinsic Pathway, Inhibiting Nuclear Factor-κB Signaling in HER2-overexpressing Breast Cancer Cells

被引:1
作者
Seo, Hye Sook [1 ,2 ]
Choi, Han Seok [1 ,2 ]
Choi, Hyeong Sim [1 ,2 ]
Choi, Youn Kyung [1 ,2 ]
Um, Jae-Young [3 ]
Choi, Inhwa [4 ]
Shin, Yong Cheol [1 ,2 ]
Ko, Seong-Gyu [1 ,2 ]
机构
[1] Kyung Hee Univ, Inst Oriental Med, Lab Clin Biol & Pharmacogenom, Seoul 130701, South Korea
[2] Kyung Hee Univ, Inst Oriental Med, Ctr Clin Res & Genom, Seoul 130701, South Korea
[3] Kyung Hee Univ, Inst Oriental Med, Dept Pharmacol, Seoul 130701, South Korea
[4] Kyung Hee Univ, Inst Oriental Med, Dept Oriental Ophthalmol Otorhinolaryngol & Derma, Seoul 130701, South Korea
关键词
Breast cancer; genistein; quercetin; apoptosis; NF kappa B; ELEMENT-BINDING PROTEIN; RESPONSE ELEMENT; TRANSCRIPTIONAL REGULATION; TUMOR ANGIOGENESIS; EXPRESSION; DEATH; METASTASIS; ACTIVATION; MECHANISMS; GENISTEIN;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Phytoestrogens are known to prevent tumor induction. But their molecular mechanisms of action are largely unknown. This study aimed to examine the effect of genistein and quercetin on proliferation and apoptosis in HER2-expressing breast cancer cells. Materials and Methods: The antiproliferative effects of phytoestrogens were tested by proliferation assays. Flow cytometry was performed to analyze the cell cycle. The effect of phytoestrogens on cell-signaling molecules was determined by Western blotting. Results: Genistein and quercetin inhibited the proliferation of MCF-7 vec and MCF-7 HER2 cells. This growth inhibition was accompanied with an increase of subG(0)/G(1) apoptotic fractions. Genistein and quercetin induced extrinsic apoptosis pathway, up-regulating p53. Genistein and quercetin reduced the phosphorylation level of I kappa B alpha, and abrogated the nuclear translocation of p65 and its phosphorylation within the nucleus. Conclusion: Genistein and quercetin exert their antiproliferative activity by inhibiting NF kappa B signaling. Phytoestrogens could be potential useful compounds to prevent or treat HER2-overexpressing breast cancer.
引用
收藏
页码:3301 / 3313
页数:13
相关论文
共 47 条
  • [31] p53-dependent apoptosis pathways
    Shen, Y
    White, E
    [J]. ADVANCES IN CANCER RESEARCH, VOL 82, 2001, 82 : 55 - +
  • [32] Expression of active Akt protects against tamoxifen-induced apoptosis in MCF-7 cells
    Shin, Incheol
    Arteaga, Carlos L.
    [J]. IUBMB LIFE, 2006, 58 (11) : 664 - 669
  • [33] Soy phytochemicals prevent orthotopic growth and metastasis of bladder cancer in mice by alterations of cancer cell proliferation and apoptosis and tumor angiogenesis
    Singh, AV
    Franke, AA
    Blackburn, GL
    Zhou, JR
    [J]. CANCER RESEARCH, 2006, 66 (03) : 1851 - 1858
  • [34] Phytoestrogens: End of a tale?
    Sirtori, CR
    Arnoldi, A
    Johnson, SK
    [J]. ANNALS OF MEDICINE, 2005, 37 (06) : 423 - 438
  • [35] Effect of short-term phytoestrogen treatment in male rats on nitric oxide-mediated responses of carotid and cerebral arteries:: Comparison with 17β-estradiol
    Sobey, CG
    Weiler, JM
    Boujaoude, M
    Woodman, OL
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 310 (01) : 135 - 140
  • [36] her-2 upstream open reading frame effects on the use of downstream initiation codons
    Spevak, Christina C.
    Park, Eun-Hee
    Geballe, Adam P.
    Pelletier, Jerry
    Sachs, Matthew S.
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 350 (04) : 834 - 841
  • [37] Role of the p53-homologue p73 in EZF1-induced apoptosis
    Stiewe, T
    Pützer, BM
    [J]. NATURE GENETICS, 2000, 26 (04) : 464 - 469
  • [38] Trastuzumab and breast cancer: Developments and current status
    Tokunaga E.
    Oki E.
    Nishida K.
    Koga T.
    Egashira A.
    Morita M.
    Kakeji Y.
    Maehara Y.
    [J]. International Journal of Clinical Oncology, 2006, 11 (3) : 199 - 208
  • [39] Mechanisms of Trastuzumab Resistance in Breast Cancer
    Tolaney, Sara M.
    Krop, Ian E.
    [J]. ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2009, 9 (03) : 348 - 355
  • [40] Toyomura Kengo, 2002, Asian Pac J Cancer Prev, V3, P125